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Treating for Two: 
A National Strategy for Safer Medication Use in Pregnancy
Medication use during pregnancy is common and increasing. Almost all pregnant 
women face decisions about whether or not it is safe to take a medication during 
pregnancy. Should Elizabeth continue taking her allergy medicine while pregnant? 
Should Clara take a medication to alleviate her nausea and vomiting? Marie just 
found out that she’s pregnant; should she switch her antidepressant to a safer one? 
Women and healthcare providers don’t have enough information to answer 
these questions. Treating for Two is CDC’s prescription for this problem. 
Medication use in pregnancy is common, but safety information  
is lacking
 • Many women need to take medication during pregnancy to 
appropriately manage their health conditions. In some cases, avoiding or 
stopping medication use during pregnancy may be more harmful than 
taking a medication.
 • At the same time, taking certain medications in pregnancy, like 
isotretinoin (also known as Accutane®), is known to cause serious birth 
defects or poor pregnancy outcomes. 
 • However, fewer than 10% of medications have enough information to 
determine their safety for use in pregnancy.  
Treating for Two is CDC‘s prescription for this problem 
CDC’s Treating for Two Initiative aims to improve the health of women and 
babies by working to identify the safest treatment options for the management 
of common conditions before and during pregnancy. The initiative aligns with 
three key drivers of safer medication use in pregnancy: better research, reliable 
guidance, and informed decisions. 
Better research: We will expand and accelerate research on medication 
use and pregnancy outcomes.
Reliable guidance: We will establish an ongoing process to  
evaluate current evidence and translate this evidence into summary  
clinical guidance.  
Informed decisions: We will provide credible and reliable  
information to help prescribers, pharmacists, and consumers make 
treatment decisions.
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CDC is translating data into action
The information gaps are large, but we are taking important steps toward 
achieving the goals of Treating for Two. Here are a few examples of our 
efforts to address issues around safer medication use in pregnancy:
Understanding knowledge, attitudes, and behaviors around medication 
use in pregnancy
In collaboration with the March of Dimes, we launched a research project 
to better understand women’s knowledge and use of medications during 
pregnancy. This effort will help us provide appropriate guidance to  
women in the future. In a parallel study we are looking at how healthcare 
providers and pharmacists counsel women on the risks of medication use 
during pregnancy.
Building the evidence base around safety and risks of medications  
in pregnancy
Through Treating for Two, we strive to quantify the problem and understand 
safety and risks of certain medications used during pregnancy.  Since 
launching the initiative, we have identified the medications most commonly 
used by women during the first trimester of pregnancy, found that there 
is limited information on the safety or risks of medications listed as “safe” 
on many web sites used by women, and confirmed a previous finding that 
women who used opioid prescription painkillers in early pregnancy had an 
increased risk of having a baby with spina bifida, a serious birth defect of  
the spine.
Increasing accessibility of information
We launched a new Treating for Two website to provide valuable resources 
to women, families, and healthcare professionals.
Partnerships are key to Treating for Two’s success
Partners are essential every step of the way to promote and advance our 
initiative and reach our target audiences. A coordinated effort between 
federal agencies and non-federal partners will advance and sustain this 
national public health-healthcare strategy. A large and growing interagency 
workgroup is dedicated to Treating for Two activities, driving forward the 
science, communication, and policy efforts. In addition, we’ve engaged 
several academic and professional organizations and continue to expand our 
partnership network. Through these collaborations, we can turn information 
into action that improves the health of women and babies.
 
For more information on Treating for Two, visit www.cdc.gov/treatingfortwo 
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CDC’s National Center on Birth 
Defects and Developmental 
Disabilities strives to advance 
the health and well-being of 
our nation’s most vulnerable 
populations. Together with  
states, academic centers, 
healthcare providers, and other 
partners, we are working towards 
a day when all babies are born 
with the best health possible and 
every child thrives.  
